ZA826159B - Pharmaceutical formulations comprising human insulin and human c-peptide - Google Patents

Pharmaceutical formulations comprising human insulin and human c-peptide

Info

Publication number
ZA826159B
ZA826159B ZA826159A ZA826159A ZA826159B ZA 826159 B ZA826159 B ZA 826159B ZA 826159 A ZA826159 A ZA 826159A ZA 826159 A ZA826159 A ZA 826159A ZA 826159 B ZA826159 B ZA 826159B
Authority
ZA
South Africa
Prior art keywords
human
peptide
pharmaceutical formulations
insulin
human insulin
Prior art date
Application number
ZA826159A
Inventor
Ronald Eugene Chance
Hill Frank Bruce
John Allison Galloway
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA826159B publication Critical patent/ZA826159B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA826159A 1981-08-27 1982-08-24 Pharmaceutical formulations comprising human insulin and human c-peptide ZA826159B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29671581A 1981-08-27 1981-08-27

Publications (1)

Publication Number Publication Date
ZA826159B true ZA826159B (en) 1984-04-25

Family

ID=23143238

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA826159A ZA826159B (en) 1981-08-27 1982-08-24 Pharmaceutical formulations comprising human insulin and human c-peptide

Country Status (20)

Country Link
JP (1) JPS5846024A (en)
AU (1) AU551879B2 (en)
BE (1) BE894185A (en)
CA (1) CA1176158A (en)
CH (1) CH650679A5 (en)
DE (1) DE3232034A1 (en)
DZ (1) DZ452A1 (en)
FR (1) FR2513126B1 (en)
GB (1) GB2104382B (en)
IE (1) IE54119B1 (en)
IL (1) IL66611A0 (en)
IT (1) IT1153182B (en)
LU (1) LU84359A1 (en)
MW (1) MW3882A1 (en)
NL (1) NL192192C (en)
NZ (1) NZ201682A (en)
PH (1) PH19361A (en)
SE (1) SE460334B (en)
ZA (1) ZA826159B (en)
ZW (1) ZW17482A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (en) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt PHARMACEUTICAL AGENT FOR TREATING THE DIABETES MELLITUS
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
AU8175387A (en) * 1986-10-20 1988-05-06 Novo Industri A/S Protamine zinc insulin preparations
IE62879B1 (en) * 1987-02-25 1995-03-08 Novo Nordisk As Novel insulin derivatives
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
EP0303308B1 (en) * 1987-08-14 1991-05-29 Akzo N.V. Preparation for preventing or combating complications in diabetes
SE520392C2 (en) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specific peptides for the treatment of diabetes mellitus
GB0323979D0 (en) 2003-10-13 2003-11-19 Creative Peptides Sweden Ab Therapeutic applications for c-peptide
CN101060856B (en) * 2004-11-22 2011-01-19 诺和诺德公司 Soluble, stable insulin-containing formulations with a protamine salt
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
WO2010033207A1 (en) 2008-09-19 2010-03-25 Nektar Therapeutics Polymer conjugates of therapeutic peptides
KR20130115086A (en) * 2010-05-17 2013-10-21 세빅스 인코포레이티드 Pegylated c-peptide
CN104220086A (en) 2011-11-17 2014-12-17 塞比克斯股份公司 PEGylated C-peptide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (en) * 1953-09-08 1958-05-31 British Drug Houses Ltd Process for the production of an insulin preparation with an extended duration of action

Also Published As

Publication number Publication date
NL192192C (en) 1997-03-04
GB2104382B (en) 1984-12-19
NL192192B (en) 1996-11-01
AU551879B2 (en) 1986-05-15
DE3232034C2 (en) 1991-04-11
IT1153182B (en) 1987-01-14
IL66611A0 (en) 1982-12-31
AU8759482A (en) 1983-03-03
NZ201682A (en) 1985-08-16
SE460334B (en) 1989-10-02
SE8204873D0 (en) 1982-08-25
JPS5846024A (en) 1983-03-17
DZ452A1 (en) 2004-09-13
MW3882A1 (en) 1984-07-11
FR2513126B1 (en) 1986-04-18
GB2104382A (en) 1983-03-09
IE822064L (en) 1983-02-27
IE54119B1 (en) 1989-06-21
IT8223017A0 (en) 1982-08-27
DE3232034A1 (en) 1983-03-10
CH650679A5 (en) 1985-08-15
NL8203315A (en) 1983-03-16
PH19361A (en) 1986-04-02
BE894185A (en) 1983-02-24
FR2513126A1 (en) 1983-03-25
ZW17482A1 (en) 1982-11-17
CA1176158A (en) 1984-10-16
LU84359A1 (en) 1983-02-28
SE8204873L (en) 1983-02-28

Similar Documents

Publication Publication Date Title
GB2105191B (en) Pharmaceutical formulations comprising human insulin and human proinsulin
GB2104382B (en) Pharmaceutical formulations comprising human insulin and human c-peptide
AU549066B2 (en) Preparation of human insulin
GB2106115B (en) Pharmaceutical amides, and preparation, formulations and use thereof
GB2104380B (en) Human proinsulin pharmaceutical formulations
ZW17682A1 (en) Pharmaceutical formulations comprising human insulin human c-peptide and human proinsulin
ZA827001B (en) Pharmaceutical amides,and preparation,formulations and use thereof
JPS57209227A (en) Insulin medicine and manufacture
IE812104L (en) Novel insulin formulations based on human insulin
JO1238B1 (en) pharmaceutical formulations comprising human insulin ,human c-peptide ,and human proinsuline
JO1236B1 (en) pharmaceutical formulations comprising human insulin and human c-peptide
IE822065L (en) Insulin and proinsulin formulations
JO1209B1 (en) Pharmaceutical formulations comprising human insulin and human proinsulin.